枫蓼肠胃康的研究进展  

Research progress on Fengliao Changweikang

作　　者：赵丹[1,2] 安妮[1,2] 陈常玉 张彩云[2] 桂梅[2] 张小坡[2] 

机构地区：[1]哈尔滨商业大学生命科学与环境科学研究中心,黑龙江哈尔滨150076 [2]海南医学院药学院,海南海口571101

出　　处：《现代药物与临床》2014年第12期1446-1450,共5页Drugs & Clinic

基　　金：国家自然科学基金资助项目(81202994)

摘　　要：枫蓼肠胃康由牛耳枫、辣蓼组成。研究表明,该复方中含有补身烷倍半萜类、黄酮类、生物碱类、有机酸类等化学成分,具有保护胃黏膜、抗溃疡性结肠炎、抗炎镇痛、抗菌等多方面的药理作用。在临床上常用的有枫蓼肠胃康颗粒剂、片剂、冲剂等,多用于急性肠胃炎、肠易激综合征、溃疡性结肠炎等。综述枫蓼肠胃康化学成分、药理作用、临床应用的研究进展,为其进一步研究和开发提供科学依据。Fengliao Changweikang is composed of Daphniphyllum calycinum and Polygonum hydropiper. The study shows that Fengliao Changweikang contains sesquiterpenoids, flavonoids, alkaloids, and organic acids. These chemical constituents play important roles in protecting the stomach lining, anti-ulcerous colitis, anti-inflammation, and anti-microbial. Clinically, granules, tablets, and electuary are commonly prescribed by doctors to cure acute gastroenteritis, irritable bowel syndrome, and ulcerative colitis. This paper summarizes the research progress on chemical constituents, pharmacology, and clinic usage of Fengliao Changweikang to provide scientific evidence for further researches and development concerning this patent Chinese medicine.

关 键 词：枫蓼肠胃康 化学成分 药理作用 临床应用 

分 类 号：R975[医药卫生—药品]